SeekingAlpha · Aug 10, 2026
Weight-Loss Drugs - How Are GLP-1s Redistributing Consumer Spending?
The recent increasing adoption of GLP-1 drugs has fundamentally changed the landscape of weight loss and health habits.
GL
OTC · GLAPY
Glanbia plc
Consumer Defensive · Packaged Foods
$123.07
Up+$0.00 (+0.00%)
Updated Sep 12, 2026, 12:14 PM
SID Score
4.7/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 4.48B
- P/E ratio
- 36.4
- Dividend yield
- 1.80%
- 52-week range
- — – —
- Volume
- 1
- Avg. volume
- 4
Price performance
GLAPY price history
1M range · 0 trading sessions · Daily adjusted prices
GLAPY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest GLAPY news
The latest Smart Investors Daily articles mentioning GLAPY.
Stock researchCompany · Overview
GLAPY research
Overview
Company profile and research snapshot.
Company profile
GLANBIA PLC S/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Yahoo · Aug 6, 2026
[Latest] Global Nutritional Market Size/Share Worth USD 1,819.6 Billion by 2034 at a 10.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Nutritional Market size & share revenue was valued at approximately USD 660.6 Billion in 2024 and is expected to reach USD 731.9 Billion in 2025 and is expected to reach around USD 1,819.6 Billion by 2034, at a CAGR of 10.6% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Glanbia Plc, Abbott Laboratorie
Yahoo · Aug 6, 2026
Glanbia PLC (GLAPF) (H1 2026) Earnings Call Highlights: EPS Soars 30% as Optimum Nutrition ...
Company raises full-year guidance to 17-20% growth despite whey cost headwinds and consumer elasticity concerns.
Yahoo · Aug 6, 2026
Glanbia bulks up forecasts amid protein demand
The Optimum Nutrition and Isopure owner now expects adjusted earnings per share to grow 17-20% on a constant-currency basis in 2026.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
